Description: Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Home Page: www.siemens-healthineers.com
Henkestrasse 127
Erlangen,
91052
Germany
Phone:
49 9131 84 3385
Officers
| Name | Title |
|---|---|
| Dr. Bernhard Montag | Pres, CEO & Chairman of Management Board |
| Dr. Jochen Schmitz | CFO & Member of Management Board |
| Ms. Darleen Caron | Chief HR Officer, Labor Director & Member of Management Board |
| Ms. Elisabeth Staudinger | Member of Management Board |
| Mr. Marc Koebernick | Head of Investor Relations |
| Dr. Michel Therin D.V.M., Ph.D. | Pres of Advanced Therapies |
| Christian Klaussner | Exec. VP of Fin. |
| Andre Hartung | Head of Imaging |
| Mr. Christopher A. Toth | Head of Varian |
| Carsten Bertram | Head of Advanced Therapies |
Exchange: F
Country: DE
Currency: Euro (€)
| Forward PE: | 24.2718 |
|---|---|
| Trailing PE: | 29.2047 |
| Price-to-Book MRQ: | 3.1221 |
| Price-to-Sales TTM: | 2.4817 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 69500 |